Harada Y - Search Results

1

AML1 mutations induced MDS and MDS/AML in a mouse BMT model.

Watanabe-Okochi N, Kitaura J, Ono R, Harada H, Harada Y, Komeno Y, Nakajima H, Nosaka T, Inaba T, Kitamura T. Watanabe-Okochi N, et al. Among authors: harada h, harada y. Blood. 2008 Apr 15;111(8):4297-308. doi: 10.1182/blood-2007-01-068346. Epub 2008 Jan 11. Blood. 2008. PMID: 18192504 Free article.

2

HERF1, a novel hematopoiesis-specific RING finger protein, is required for terminal differentiation of erythroid cells.

Harada H, Harada Y, O'Brien DP, Rice DS, Naeve CW, Downing JR. Harada H, et al. Among authors: harada y. Mol Cell Biol. 1999 May;19(5):3808-15. doi: 10.1128/MCB.19.5.3808. Mol Cell Biol. 1999. PMID: 10207104 Free PMC article.

3

Implications of somatic mutations in the AML1 gene in radiation-associated and therapy-related myelodysplastic syndrome/acute myeloid leukemia.

Harada H, Harada Y, Tanaka H, Kimura A, Inaba T. Harada H, et al. Among authors: harada y. Blood. 2003 Jan 15;101(2):673-80. doi: 10.1182/blood-2002-04-1010. Epub 2002 Sep 5. Blood. 2003. PMID: 12393679 Free article.

4

High incidence of somatic mutations in the AML1/RUNX1 gene in myelodysplastic syndrome and low blast percentage myeloid leukemia with myelodysplasia.

Harada H, Harada Y, Niimi H, Kyo T, Kimura A, Inaba T. Harada H, et al. Among authors: harada y. Blood. 2004 Mar 15;103(6):2316-24. doi: 10.1182/blood-2003-09-3074. Epub 2003 Nov 13. Blood. 2004. PMID: 14615365 Free article.

5

Point mutations in the AML1/RUNX1 gene associated with myelodysplastic syndrome.

Harada H, Harada Y. Harada H, et al. Among authors: harada y. Crit Rev Eukaryot Gene Expr. 2005;15(3):183-96. doi: 10.1615/critreveukargeneexpr.v15.i3.10. Crit Rev Eukaryot Gene Expr. 2005. PMID: 16390315 Review.

6

Implications of somatic mutations in the AML1/RUNX1 gene in myelodysplastic syndrome (MDS): future molecular therapeutic directions for MDS.

Harada H, Harada Y, Kimura A. Harada H, et al. Among authors: harada y. Curr Cancer Drug Targets. 2006 Sep;6(6):553-65. doi: 10.2174/156800906778194595. Curr Cancer Drug Targets. 2006. PMID: 17017876 Review.

7

High frequency of AML1/RUNX1 point mutations in radiation-associated myelodysplastic syndrome around Semipalatinsk nuclear test site.

Zharlyganova D, Harada H, Harada Y, Shinkarev S, Zhumadilov Z, Zhunusova A, Tchaizhunusova NJ, Apsalikov KN, Kemaikin V, Zhumadilov K, Kawano N, Kimura A, Hoshi M. Zharlyganova D, et al. Among authors: harada h, harada y. J Radiat Res. 2008 Sep;49(5):549-55. doi: 10.1269/jrr.08040. Epub 2008 Aug 23. J Radiat Res. 2008. PMID: 18724045 Free article.

8

Molecular pathways mediating MDS/AML with focus on AML1/RUNX1 point mutations.

Harada Y, Harada H. Harada Y, et al. Among authors: harada h. J Cell Physiol. 2009 Jul;220(1):16-20. doi: 10.1002/jcp.21769. J Cell Physiol. 2009. PMID: 19334039 Review.

9

Possible involvement of RasGRP4 in leukemogenesis.

Watanabe-Okochi N, Oki T, Komeno Y, Kato N, Yuji K, Ono R, Harada Y, Harada H, Hayashi Y, Nakajima H, Nosaka T, Kitaura J, Kitamura T. Watanabe-Okochi N, et al. Among authors: harada h, harada y. Int J Hematol. 2009 May;89(4):470-481. doi: 10.1007/s12185-009-0299-0. Epub 2009 Apr 7. Int J Hematol. 2009. PMID: 19350351

10

AML1/RUNX1 point mutation possibly promotes leukemic transformation in myeloproliferative neoplasms.

Ding Y, Harada Y, Imagawa J, Kimura A, Harada H. Ding Y, et al. Among authors: harada h, harada y. Blood. 2009 Dec 10;114(25):5201-5. doi: 10.1182/blood-2009-06-223982. Blood. 2009. PMID: 19850737 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,760 results

Search Page